We rely on prominent scientists and physicians to advise us on the clinical development of our infectious disease compounds.

Dani Bolognesi, Ph.D.
Chairman and CEO B3Bio, Inc.

Paul Grint, M.D.
Leading Clinical Researcher

Gail Skowron, MD, FACP, FIDSA
Chief, Division of Infectious Diseases
Roger Williams Medical Center
Associate Professor of Medicine
Boston University School of Medicine.

Michael Varney, Ph.D.
Vice President, Small Molecule Drug Discovery Genentech

Roscoe Moore Jr., D.V.M., Ph.D., D.Sc
President, PH RockWood Corporation, Rockville, Maryland and Pretoria, South Africa
Former Assistant United States Surgeon General
Rear Admiral, United States Public Health Service (Retired)

Israel F. Charo, MD, PhD
Senior Investigator/Associate Director
Gladstone Institute of Cardiovascular Disease
San Francisco, California